This activity is supported by an unrestricted educational grant from Taiho Oncology, Inc.
Updates in the Treatment of Metastatic Colorectal Cancer
John Marshall, MD
Robin Sommers, DNP, ANP-BC, AOCNP
Dana-Farber Cancer Institute
Ongoing research in the area of metastatic colorectal cancer makes it imperative for the AP to stay informed and knowledgeable about new treatment options. Learn crucial information about current treatment options, mutation testing and the impact on treatment decisions, predictive biomarkers, the role of radiation, and the role of biologics and oral therapies in the management of mCRC.
These CME/CE/CPE accredited activities are jointly provided by